Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study.

Young Gun KimJa Young JeonHae Jin KimDae-Jung KimKwan-Woo LeeSo Young MoonSeung Jin Han

Published in: Journal of clinical medicine (2018)

Our findings suggest that DPP-4i use decreases the risk of dementia compared to SU use in elderly patients with type 2 diabetes in a real-world clinical setting.

Keyphrases

mild cognitive impairment
community dwelling
middle aged
cognitive impairment
physical activity